PlatformGlobal presence with facilities in the US (including Houston, Texas) and the UK.Founded 2017· One of 203 Platform companies tracked by AMPulse
Digital planning and point-of-care 3D printed personalized surgical guides, implants, and anatomical models designed to enhance precision and efficiency in surgical procedures.
Virtual surgical planning, patient-specific surgical guides, models, and custom implants for orthopedic and other surgical procedures.
Technological Advantage
Rapid, localized manufacturing with FDA and ISO approval ensuring improved patient outcomes and operational cost optimization.
Differentiation
Value Proposition
Enhanced precision and efficiency in surgical procedures through rapid (days, not weeks) delivery of customized 3D printed guides, implants, and models.
How They Differentiate
Focus on rapid, point-of-care 3D printed personalized surgical solutions with direct clinician collaboration.
Market & Competition
Target Customers
Surgeons and medical institutions, particularly in orthopedics, pediatric orthopedics, and oncology.
Industry Verticals
["Healthcare","Surgical Services"]
Competitors
Materialise; Stryker; Zimmer Biomet
Growth & Milestones
Growth Metrics
Expanding US presence with plans to double the headcount and open new manufacturing facilities.
Major Milestones
["Secured FDA 510(k) clearance for surgical guides","Completed $2.5M Series A funding","Established manufacturing facility at Texas Medical Center in Houston","Acquired and integrated 3D LifePrints","Opened Centre of Excellence at Manchester Science Park, UK","Partnered with Children's Nebraska for pediatric care"]
Notable Customers
Alder Hey Children's Hospital NHS, Children's Nebraska, Hospital for Special Surgery (New York), University Hospitals of Chicago, University of Florida Health, UAB (Birmingham Alabama)
Insight Surgery occupies a niche at the intersection of personalized medicine and localized additive manufacturing. Founded in 2017, the company targets a gap in the surgical device supply chain: the weeks-long turnaround for traditional patient-specific implants and guides. By bringing design and polymer 3D printing directly to or near the point of care, Insight Surgery aims to compress that timeline to days while maintaining regulatory compliance.
The core of the offering is the proprietary EmbedMed digital platform, which automates the design and manufacture of patient-specific surgical devices. Outputs include virtual surgical planning, anatomical models, surgical guides, and custom implants, all produced via polymer additive manufacturing. The company holds FDA 510(k) clearance for its surgical guides and operates under ISO quality management standards, with facilities in Houston, Texas, and the UK.
Target customers are surgeons and medical institutions, particularly in orthopedics, pediatric orthopedics, and oncology. Named hospital partners include Alder Hey Children's Hospital NHS, Children's Nebraska, Hospital for Special Surgery in New York, University Hospitals of Chicago, University of Florida Health, and UAB in Birmingham, Alabama. The company also acquired and integrated 3D LifePrints, a UK-based point-of-care 3D printing service, to expand its clinical footprint.
Insight Surgery competes with established medical device OEMs such as Stryker and Zimmer Biomet, as well as software and service providers like Materialise. Its differentiation lies in rapid, localized manufacturing combined with direct clinician collaboration via the EmbedMed platform. The company has raised $5.93M from investors including Nodenza Venture Partners, Bigspace Investments, and Fenwall Investments, and plans to double headcount and open additional US manufacturing facilities.
Competitive Intelligence
Competitors, SWOT analysis, and investment insights